Does DOSTARLIMAB-GXLY Cause Urinary tract infection? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Urinary tract infection have been filed in association with DOSTARLIMAB-GXLY. This represents 1.6% of all adverse event reports for DOSTARLIMAB-GXLY.
8
Reports of Urinary tract infection with DOSTARLIMAB-GXLY
1.6%
of all DOSTARLIMAB-GXLY reports
0
Deaths
3
Hospitalizations
How Dangerous Is Urinary tract infection From DOSTARLIMAB-GXLY?
Of the 8 reports, 3 (37.5%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Urinary tract infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOSTARLIMAB-GXLY. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does DOSTARLIMAB-GXLY Cause?
Off label use (51)
Rash (42)
Death (28)
Malignant neoplasm progression (28)
Fatigue (22)
Neuropathy peripheral (20)
Pyrexia (20)
Product use in unapproved indication (19)
Thrombocytopenia (16)
Hypothyroidism (14)
What Other Drugs Cause Urinary tract infection?
ADALIMUMAB (6,375)
LENALIDOMIDE (4,247)
ETANERCEPT (3,915)
OCRELIZUMAB (3,618)
TOFACITINIB (3,179)
METHOTREXATE (2,960)
DALFAMPRIDINE (2,757)
RITUXIMAB (2,579)
CARBIDOPA\LEVODOPA (2,151)
ABATACEPT (2,110)
Which DOSTARLIMAB-GXLY Alternatives Have Lower Urinary tract infection Risk?
DOSTARLIMAB-GXLY vs DOTATATE GALLIUM GA-68
DOSTARLIMAB-GXLY vs DOTHIEPIN
DOSTARLIMAB-GXLY vs DOXAZOSIN
DOSTARLIMAB-GXLY vs DOXAZOSIN\DOXAZOSIN
DOSTARLIMAB-GXLY vs DOXEPIN